Patents Assigned to JD BIOSCIENCE INC.
  • Tricyclic compound and pharmaceutical use thereof
    Patent number: 12662461
    Abstract: A compound of the present invention, which is a tricyclic derivative represented by chemical formula 1 or a pharmaceutically acceptable salt thereof, has an excellent inhibitory effect on serotonin activity and a pharmaceutical composition comprising same can be thus advantageously used for preventing or treating a metabolic disease associated with serotonin activation, etc.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: June 23, 2026
    Assignee: JD BIOSCIENCE INC.
    Inventors: Haushabhau Shivaji Pagire, Suvarna Haushabhau Pagire, Min Hee Kim, Won Mi Lee, Jin Hee Ahn, Sung Min Song, Heejong Lee, Dooseop Kim, Eun Young Lee
  • TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20230002349
    Abstract: A compound of the present invention, which is a tricyclic derivative represented by chemical formula 1 or a pharmaceutically acceptable salt thereof, has an excellent inhibitory effect on serotonin activity and a pharmaceutical composition comprising same can be thus advantageously used for preventing or treating a metabolic disease associated with serotonin activation, etc.
    Type: Application
    Filed: October 30, 2020
    Publication date: January 5, 2023
    Applicant: JD BIOSCIENCE INC.
    Inventors: Haushabhau Shivaji PAGIRE, Suvarna Haushabhau PAGIRE, Min Hee KIM, Won Mi LEE, Jin Hee AHN, Sung Min SONG, Heejong LEE, Dooseop KIM, Eun Young LEE